The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

I. To develop and assess a targeted educational initiative to improve compliance with NCCN CRC and NSCLC survivorship guidelines for oncology health care providers in academic and community practice.

II. To evaluate the impact of this educational initiative on documented adherence and compliance with NCCN guidelines for NSCLC and CRC survivorship care by oncology health care providers.

OUTLINE:

Health care providers complete an educational intervention based on NCCN guidelines in CRC and NSCLC survivorship care comprising a power point presentation reviewing evidence and guidelines; a USB drive of the NCCN guidelines with paper copy of pages addressing survivorship care; an electronic and paper copy of a sample survivorship clinic template note with prompts for addressing survivorship care components; and an electronic paper copy sample survivorship care plan that can be adapted and distributed at each participating site.

Health care providers complete an educational intervention based on NCCN guidelines in CRC and NSCLC survivorship care comprising a power point presentation reviewing evidence and prompts for addressing survivorship care components; and an electronic paper copy sample survivorship care plan that can be adapted and distributed at each participating site.

Other: educational intervention

Complete an educational intervention based on NCCN guidelines and disease-specific issues related to survivorship care

Percentage of eligible CRC and NSCLC survivors with medical record documentation of compliance with NCCN guidelines [ Time Frame: Up to 6 months ]

A test of the binomial proportion will have 99% power with 1% type I error to make this distinction.

Secondary Outcome Measures :

Change in percentage of eligible survivors with documentation of compliance with NCCN survivorship guidelines after conducting the targeted educational initiative at participating sites [ Time Frame: Baseline and up to 6 months ]

This two-sample test of binomial proportions will have 99% power with 1% type I error.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Patients must have completed all therapy for curative intent at least six months prior to chart audit

Undergoing routine oncology care and surveillance at the chosen site (defined as receiving follow-up care with FCCC or FCCCP site health care providers and have an active medical chart)

No evidence of metastatic disease

Patients must have been seen for a visit for cancer surveillance between 2009 and 2013

Health care providers at the participating site must be willing and able to participate in the educational initiative

CHART AUDIT INCLUSION CRITERIA (POST-INTERVENTION)

Charts eligible for audit after completion of the educational initiative will be for those CRC and NSCLC survivors presenting for follow-up after the initiative has been completed by site health care providers

Exclusion Criteria:

CHART AUDIT EXCLUSION CRITERIA:

Cancer Registry cases for diseases other than colon or rectal adenocarcinoma and non-small cell lung cancer (squamous or adenocarcinoma histology)

Patients currently receiving active therapy for any cancer, including CRC or NSCLC

Patients who do not undergo routine oncologic care at the chosen Partners site or Fox Chase Cancer Center

Stage IV cancer or evidence of metastatic disease at any time point

Patients who have not undergone a visit for cancer surveillance since 2009

Fox Chase Cancer Partners sites who do not agree to chart audit procedures or providers are unable or unwilling to participate in the educational initiative